Rocket Lab stock has delivered a very large 3 year gain, yet the valuation checks now point to a richer pricing, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples indicating the shares trade at a premium rather than a clear bargain.

• Over the past 3 years, Rocket Lab has returned about 16x, which sets a high bar for any further upside to be justified by future cash flows.
• The planned acquisition of Iridium Communications and expansion into vertically integrated space services can support long term revenue hopes, but execution risks around large deals and capital needs may weigh on what investors are willing to pay today.
• On the broader checks, Rocket Lab scores 0 out of 6 for value at https://www.simplywall.st/stocks/us/capital-goods/nasdaq-rklb/rocket-lab/valuation, which points to a stock that currently looks expensive rather than obviously mispriced.

The issue now is whether Rocket Lab’s recent share price level leaves enough valuation support once expectations around growth, profitability, and the Iridium deal are taken into account.

Does Rocket Lab Look Pricey on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what Rocket Lab shares might be worth based on projected future cash generation. For Rocket Lab, the latest twelve month free cash flow shows a cash outflow of about $300.8 million, and the model assumes a recovering path where free cash flow eventually turns positive and grows from there. On those inputs, the 2 Stage Free Cash Flow to Equity model points to an intrinsic value of about $72.66 per share.

Compared with the current share price, that output implies the stock trades at roughly a 39.9% premium to the modelled intrinsic value. On this cash flow view, Rocket Lab screens as overvalued. The planned $8 billion Iridium Communications deal, with its mix of cash needs and expected recurring revenue, helps explain why the market is already pricing in very optimistic long term cash flow expectations.

Overall, the DCF workup suggests Rocket Lab stock currently looks overvalued relative to the cash flows baked into this model.

Our Discounted Cash Flow (DCF) analysis suggests Rocket Lab may be overvalued by 39.9%. Discover 43 high quality undervalued stocks or create your own screener to find better value opportunities.

Is Rocket Lab Getting Expensive on Book Value?

P/B is a useful cross check for Rocket Lab because it is still building profitability, so the balance sheet carries a lot of the story. On this measure, Rocket Lab trades at a P/B of about 26.0x, compared with an Aerospace & Defense industry average near 3.8x and a peer group around 22.6x.

That premium suggests investors are paying a high price for each dollar of Rocket Lab’s equity. The gap to the sector is wide, and even versus peers the stock sits toward the expensive end of the range, especially given ongoing cash burn and execution risks around Iridium and Neutron. In this framework, the P/B signal reads more as a warning flag about rich expectations rather than as a fine tuned estimate of what the multiple should be.

Overall, Rocket Lab appears expensive on the P/B multiple, with the share price reflecting a steep premium to both its industry and peer benchmarks.

The Rocket Lab Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Rocket Lab pick up where the valuation work leaves off by spelling out which assumptions about Rocket Lab’s future growth, margins and earnings would have to hold for the stock to be worth materially more or less than today’s price, and they sit on the company’s Community page. Where a ratio or model gives a single number, these narratives unpack the future that number relies on so you can watch how reality lines up with it over time.

Community views on Rocket Lab sit far apart, with one camp focused on long term earnings power and another zeroing in on execution and capital risk.

Bull case: 32% undervalued

"By fully controlling payloads, critical components, bus manufacturing, and launch, Rocket Lab is uniquely positioned as the only Western supplier able to deliver fixed price, end to end solutions for defense and constellation customers..."

Bear case: roughly fairly valued

"Rocket Lab needs to start achieving positive net margins so it can transform from being a company that burns shareholder funds into one that earns enough cash to self invest into its growth..."

Do you think there's more to the story for Rocket Lab? Head over to our Community to see what others are saying!

The Bottom Line

For Rocket Lab, both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple workups currently point to the same conclusion: the stock screens as overvalued rather than obviously cheap. The extreme move in the share price and the wide gap to typical sector multiples suggest expectations are already demanding, while the broader valuation checks remain weak.

From here, the crux of the Rocket Lab debate is whether the company can deliver the cash flow turnaround and execution on Iridium and Neutron that would make today’s premium look justified instead of stretched.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.